1. Home
  2. PLSE vs FORTY Comparison

PLSE vs FORTY Comparison

Compare PLSE & FORTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • FORTY
  • Stock Information
  • Founded
  • PLSE 2014
  • FORTY 1985
  • Country
  • PLSE United States
  • FORTY Israel
  • Employees
  • PLSE N/A
  • FORTY N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • FORTY EDP Services
  • Sector
  • PLSE Health Care
  • FORTY Technology
  • Exchange
  • PLSE Nasdaq
  • FORTY Nasdaq
  • Market Cap
  • PLSE 1.1B
  • FORTY 1.3B
  • IPO Year
  • PLSE 2016
  • FORTY 1997
  • Fundamental
  • Price
  • PLSE $17.32
  • FORTY $110.00
  • Analyst Decision
  • PLSE
  • FORTY
  • Analyst Count
  • PLSE 0
  • FORTY 0
  • Target Price
  • PLSE N/A
  • FORTY N/A
  • AVG Volume (30 Days)
  • PLSE 154.2K
  • FORTY 356.0
  • Earning Date
  • PLSE 05-08-2025
  • FORTY 05-22-2025
  • Dividend Yield
  • PLSE N/A
  • FORTY 1.16%
  • EPS Growth
  • PLSE N/A
  • FORTY 25.14
  • EPS
  • PLSE N/A
  • FORTY 5.21
  • Revenue
  • PLSE N/A
  • FORTY $2,813,792,000.00
  • Revenue This Year
  • PLSE N/A
  • FORTY N/A
  • Revenue Next Year
  • PLSE N/A
  • FORTY N/A
  • P/E Ratio
  • PLSE N/A
  • FORTY $20.09
  • Revenue Growth
  • PLSE N/A
  • FORTY 5.92
  • 52 Week Low
  • PLSE $9.70
  • FORTY $69.07
  • 52 Week High
  • PLSE $25.00
  • FORTY $111.08
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 52.20
  • FORTY 74.48
  • Support Level
  • PLSE $16.75
  • FORTY $85.30
  • Resistance Level
  • PLSE $18.26
  • FORTY $100.00
  • Average True Range (ATR)
  • PLSE 0.87
  • FORTY 0.23
  • MACD
  • PLSE 0.03
  • FORTY 1.08
  • Stochastic Oscillator
  • PLSE 62.80
  • FORTY 100.00

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources; Michpal; ZAP Group and Others. The majority of the company's revenue comes from Israel.

Share on Social Networks: